The FDA has developed two consumer-friendly model Drug Facts Labels (DFLs) for over-the-counter (OTC) naloxone, a drug used to treat opioid overdose — one for use with a nasal spray and one for use with an auto-injector. These model labels contain information that a consumer needs to administer naloxone safely and effectively. With the number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017, FDA notes it is critical to enable new ways to increase availability of naloxone, such as informed OTC access.
News you can use: health & drug safety updates
January 22, 2019
January 15, 2019
There's no better time than right now to invest in your health. Odds are you do it every day — even if you don't know that's what you're doing. Continue reading...
January 10, 2019
Grandparents can help protect kids from medication-related poisonings — National Safety Council.
December 13, 2018
First, some recent, eye-opening facts: • In the US there are over 276 million registered vehicles with 222 million drivers holding a valid license. Of this number, nearly 43 million are 65 or older. That's roughly one in every five. • 40,100 people died in accidents involving motor vehicles in 2017 a 1 percent drop from the year before. Continue reading...
November 20, 2018
It will come as no surprise to many that the 65+ year old crowd - aging baby boomers and older adults - are taking a lot of over-the-counter (OTC) and prescription medicines, along with vitamins, dietary supplements and herbal remedies. As many as 55 million Americans will be older than age 65 by 2020. Continue reading...
October 24, 2018
FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids
FDA, working with international regulatory and law enforcement agencies, announced Tuesday it recently took steps to target nearly 500 websites that illegally sell potentially dangerous, unapproved prescription drugs to consumers. The initiative was part of Operation Pangea XI, the 11th annual International Internet Week of Action (IIWA). "The sale of potentially dangerous and counterfeit drugs by criminal networks on the internet is a large and growing threat to the...
October 22, 2018
Unused medications can become household dangers. Dispose of them properly on National Prescription Drug Take Back Day Saturday, October 27.
On Saturday, October 27th, law enforcement agencies across the country will be participating in the DEA's National Prescription Drug Take Back Day. Our partner Allied Against Opioid Abuse has developed a helpful resource that explains how safe disposal can help prevent misuse, along with a tool to help find a disposal location in your state.
October 12, 2018
The FDA approved or tentatively approved a record-setting 971 generic drugs in fiscal year 2018, which ended Sept. 30. The agency set a record for most complete responses in one year with 2,548. "Our work is not done. We'll continue taking additional steps to help ensure patients have access to the drugs they need by making generic drug approval more efficient and predictable," stated FDA Commissioner Scott Gottlieb.
October 10, 2018
President Donald Trump is expected to sign two bills Wednesday that ban "gag order" clauses in contracts between pharmacies and insurance companies or PBMs. Ronna Hauser, vice president of payment policy and regulatory affairs at the National Community Pharmacists Association, says many members of her group "say a PBM will call them with a warning if they are telling patients it’s less expensive" without insurance. She says pharmacists could be fined for violating their contracts and even dropped from insurance networks.
October 2, 2018
The American Society of Health-System Pharmacists (ASHP) guidelines offer best practices and recommendations for avoiding medication errors in hospitals that highlight the leadership roles that pharmacists play and opportunities for them on interprofessional teams to limit errors. The guidelines urge organizations to have a comprehensive program that includes a medication safety head, an event reporting system, a collaborative medication safety team, and a continuous quality improvement philosophy about evaluation of errors and harm.